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Epidermal growth factor receptor tyrosine kinase (EGFRtk) and endoplasmic
reticulum (ER) stress are important factors in cardiovascular complications.
Understanding whether enhanced EGFRtk activity and ER stress induction are
involved in cardiac damage, and microvascular dysfunction in type 1 diabetes mellitus
is an important question that has remained unanswered. Cardiac fibrosis and
microvascular function were determined in C57BL/6J mice injected with
streptozotocin only or in combination with EGFRtk inhibitor (AG1478), ER stress
inhibitor (Tudca), or insulin for 2 weeks. In diabetic mice, we observed an increase in
EGFRtk phosphorylation and ER stress marker expression (CHOP, ATF4, ATF6, and
phosphorylated-eIF2alpha) in heart and mesenteric resistance arteries, which were
reduced with AG1478, Tudca, and insulin. Cardiac fibrosis, enhanced collagen type I,
and plasminogen activator inhibitor 1 were decreased with AG1478, Tudca, and
insulin treatments. The impaired endothelium-dependent relaxation and -independent
relaxation responses were also restored after treatments. The inhibition of NO
synthesis reduced endothelium-dependent relaxation in control and treated
streptozotocin mice, whereas the inhibition of NADPH oxidase improved endothelium-
dependent relaxation only in streptozotocin mice. Moreover, in mesenteric resistance
arteries, the mRNA levels of Nox2 and Nox4 and the NADPH oxidase activity were
augmented in streptozotocin mice and reduced with treatments. This study unveiled
novel roles for enhanced EGFRtk phosphorylation and its downstream ER stress in
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